Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
Authors:
Open Access
- 21 April 2014
- journal article
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 17 (2) , 76-82
Abstract
The routine approach to evaluating the effectiveness of diabetes treatment based on the level of glycated haemoglobin (HbA. 1c) accounts for the average glucose level but does not consider the scope and frequency of its fluctuations. The development of computational methods to analyse glycaemic oscillations has made it possible to propose the concept of glycaemic variability (GV). The interest in research focused on GV increased dramatically after continuous glucose monitoring (CGM) technology was introduced, which provided the opportunity to study in detail the temporal structure of blood glucose curves. Numerous methods for assessing GV proposed over the past five decades characterize glycaemic fluctuations as functions of concentration and time and estimate the risks of hypoglycaemia and hyperglycaemia. Accumulating evidence indicates that GV may serve as a significant predictor of diabetic complications. Prospective studies demonstrate that certain GV parameters have independent significance for predicting diabetic retinopathy, nephropathy and cardiovascular diseases. There is evidence that GV correlates with the severity of atherosclerotic vascular lesions and cardiovascular outcomes in diabetic patients. The mechanisms underlying the relationship between GV and vascular complications are being intensively studied, and recent data show that the effect of GV on vascular walls may be mediated by oxidative stress, chronic inflammation and endothelial dysfunction. Average blood glucose levels and GV are considered independent predictors of hypoglycaemia. Increased GV is associated with impaired hormonal response to hypoglycaemia and is a long-term predictor of hypoglycaemia unawareness. These data allow us to conclude that computational methods for analysing GV in patients with diabetes may serve as a promising tool for personalized assessment of glycaemic control and the risk of vascular complications and hypoglycaemia. Thus, the reduction of GV can be regarded as one of the therapeutic targets to treat diabetes.Keywords
This publication has 44 references indexed in Scilit:
- A Simple Robust Method for Estimating the Glucose Rate of Appearance from Mixed MealsJournal of Diabetes Science and Technology, 2012
- Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic GroupsDiabetes Technology & Therapeutics, 2011
- Impact of Glycemic and Blood Pressure Variability on Surrogate Measures of Cardiovascular Outcomes in Type 2 Diabetic PatientsDiabetes Care, 2011
- Glucose Variability; Does It Matter?Endocrine Reviews, 2010
- Evaluation of a New Measure of Blood Glucose Variability in DiabetesDiabetes Care, 2006
- Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 DiabetesJAMA, 2006
- A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic VariationDiabetes Technology & Therapeutics, 2005
- Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet TransplantationDiabetes, 2004
- Algorithmic Evaluation of Metabolic Control and Risk of Severe Hypoglycemia in Type 1 and Type 2 Diabetes Using Self-Monitoring Blood Glucose DataDiabetes Technology & Therapeutics, 2003
- Episodes of Severe Hypoglycemia in Type 1 Diabetes Are Preceded and Followed within 48 Hours by Measurable Disturbances in Blood Glucose1The Journal of Clinical Endocrinology & Metabolism, 2000